Search

Your search keyword '"Kelly, Kara"' showing total 863 results

Search Constraints

Start Over You searched for: Author "Kelly, Kara" Remove constraint Author: "Kelly, Kara"
863 results on '"Kelly, Kara"'

Search Results

1. Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Patients Using a Longitudinally-Aware Segmentation Network

2. Automatic Personalized Impression Generation for PET Reports Using Large Language Models

7. Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy

8. Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults

14. Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001

17. Exposure-Response and Subgroup Analyses to Support Body Weight-Based Dosing of Brentuximab Vedotin in Children and Young Adults with Newly Diagnosed High-Risk Classical Hodgkin Lymphoma

19. Genetic ancestry and skeletal toxicities among childhood acute lymphoblastic leukemia patients in the DFCI 05-001 cohort

21. Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in Children

22. Inequitable Poverty Exposures: A Subspecialty Opportunity to Address Disparities

23. Accelerating pediatric Hodgkin lymphoma research: the Hodgkin Lymphoma Data Collaboration (NODAL).

24. Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children’s Oncology Group AHOD 1331 study

28. Impairment of health‐related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL Consortium

29. Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia

35. Prognostic value of chest x‐ray‐ and CT‐defined large mediastinal adenopathy in high‐risk pediatric Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0831

37. Abstract 6737: Exposure-response and age subgroup analyses to support body-weight (BW) dosing of brentuximab vedotin (BV) in newly diagnosed high-risk classical Hodgkin lymphoma (cHL) in children and young adults (aged 2-21 years [y]): A randomized children’s oncology group phase 3 trial (AHOD1331)

39. Radiotherapy Use in Refractory and Relapsed Adolescent and Young Adult Hodgkin Lymphoma: A Report from the Children's Oncology Group

40. Baseline metabolic tumour burden improves risk stratification in Hodgkin lymphoma: A Children's Oncology Group study

41. Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using PET Response−Adapted Radiotherapy

42. Significance of E-lesions in Hodgkin lymphoma and the creation of a new consensus definition:a report from SEARCH

46. Lymphomas

47. Intravenous pegylated asparaginase versus intramuscular native Escherichia colil-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial

49. Contributors

Catalog

Books, media, physical & digital resources